𝔖 Bobbio Scriptorium

✦ LIBER ✦

Characteristics influencing therapy switch behavior after suboptimal response to first-line treatment in patients with multiple sclerosis

✍ Scribed by Teter, B.; Agashivala, N.; Kavak, K.; Chouhfeh, L.; Hashmonay, R.; Weinstock-Guttman, B.

Book ID: 121823573
Publisher: SAGE Publications
Year: 2013
Tongue: English
Weight: 863 KB
Volume: 20
Category: Article
ISSN: 1352-4585
DOI: 10.1177/1352458513513058

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB